image credit: Unsplash

New Therapeutic Target Identified for Breast Cancer Treatment

Lemur tyrosine kinase 3 (LMTK3) is associated with cell proliferation and endocrine resistance in breast cancer. Now, a team of researchers from the University of Sussex has completed a five-year study that provides evidence for a potential new target for breast cancer treatment. It suggests that LMTK3 inhibitors could be effectively used for the treatment of breast cancer, and potentially other types of cancer.

Their five-year study, “The structure-function relationship of oncogenic LMTK3,” is published in Science Advances, involved researchers from seven institutions across three countries including the U.K.’s Diamond Light Source.

Read More on Genetic Engineering and Biotechnology News